Evaluation of β-blocker therapy in patients with dilated cardiomyopathy - Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography

American Heart Journal

Volumn 141, Issue 4, 2001, Pages 645-652

  Yamazaki, Junichi ^a   Muto, Hiroshi ^a   Kabano, Toshio ^a   Yamashina, Shohei ^a   Nanjo, Shuji ^a   Inoue, Aritomo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL; NIPRADILOL; NORADRENALIN;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART DILATATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0035095070     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.112783     Document Type: Article

References (29)

1. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy
2. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
3. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration
4. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy
5. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade
6. Benefical effects of long-term beta-blockade in congestive cardiomyopathy
7. Benefit of beta-blockers for heart failure: Proven in 1999
8. Beta blocker treatment in heart failure
9. Newer drug therapy for congestive heart failure
10. Myocardial imaging with radioiodinated norepinephrine storage analog
11. Myocardial imaging in man with I-123 meta-iodobenzyl guanidine
12. Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy
13. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial
14. 123I-MIBG by polar map in patients with dilated cardiomyopathy
15. Use of iodine-123 metaiodobenzylguanidine myocardial imaging to predict the effectiveness of β-blocker therapy in patients with dilated cardiomyopathy
16. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure
17. Prognosis value of MIBG imaging in idiopathic dilated cardiomyopathy
18. Myocardial imaging with radioiodinated norepinephrine storage analog
19. Myocardial imaging in man with I-123 meta-iodobenzyl guanidine
20. Scintigraphic assessment of MIBG uptake in globally denervated human and canine heart-implications for clinical studies
21. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
22. Dose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy
23. Etiology and response to drug treatment in heart failure
24. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to βblocker therapy in patients with dilated cardiomyopathy
25. 123I-MIBG in the failing human heart
26. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
27. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure
28. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants
29. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: Evidence for late reinnervation